BG Medicine, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BGMD research report →
Companywww.bg-medicine.com
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
- CEO
- Stephen Hall
- IPO
- 2011
- Employees
- 5
- HQ
- Waltham, MA, US
Price Chart
Valuation
- Market Cap
- $1.14K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.75%
- Op Margin
- -295.66%
- Net Margin
- -338.63%
- ROE
- 747.43%
- ROIC
- -485.83%
Growth & Income
- Revenue
- $1.57M · -43.81%
- Net Income
- $-5,303,000 · 34.24%
- EPS
- $-0.55 · 44.44%
- Op Income
- $-4,630,000
- FCF YoY
- 55.10%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -44.60
- Avg Volume
- 1.41K
Get TickerSpark's AI analysis on BGMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 4, 16 | LUBER JEFFREY R | other | 10,000 |
| Feb 4, 16 | LUBER JEFFREY R | other | 0 |
| Dec 9, 15 | AFEYAN NOUBAR | sell | 2,508 |
| Nov 18, 15 | PAPADOPOULOS STELIOS | other | 5,000 |
| Nov 18, 15 | AFEYAN NOUBAR | other | 5,000 |
| Jul 27, 15 | AFEYAN NOUBAR | other | 508 |
| Jul 27, 15 | AFEYAN NOUBAR | sell | 32 |
| Jul 27, 15 | AFEYAN NOUBAR | other | 254 |
| Jul 27, 15 | AFEYAN NOUBAR | sell | 16 |
| Jul 27, 15 | AFEYAN NOUBAR | other | 254 |
Our BGMD Coverage
We haven't published any research on BGMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BGMD Report →